ATE136465T1 - Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis - Google Patents

Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis

Info

Publication number
ATE136465T1
ATE136465T1 AT91900992T AT91900992T ATE136465T1 AT E136465 T1 ATE136465 T1 AT E136465T1 AT 91900992 T AT91900992 T AT 91900992T AT 91900992 T AT91900992 T AT 91900992T AT E136465 T1 ATE136465 T1 AT E136465T1
Authority
AT
Austria
Prior art keywords
prostatitis
treatment
gibberellins
production
medicinal product
Prior art date
Application number
AT91900992T
Other languages
English (en)
Inventor
Per Oden
Original Assignee
Per Oden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Per Oden filed Critical Per Oden
Application granted granted Critical
Publication of ATE136465T1 publication Critical patent/ATE136465T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P27/00—Preparation of compounds containing a gibbane ring system, e.g. gibberellin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT91900992T 1989-12-12 1990-12-10 Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis ATE136465T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK627289A DK627289D0 (da) 1989-12-12 1989-12-12 Anvendelse af bicyclononanderivater

Publications (1)

Publication Number Publication Date
ATE136465T1 true ATE136465T1 (de) 1996-04-15

Family

ID=8148421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900992T ATE136465T1 (de) 1989-12-12 1990-12-10 Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis

Country Status (11)

Country Link
EP (1) EP0504254B1 (de)
JP (1) JPH05502227A (de)
KR (1) KR920703088A (de)
AT (1) ATE136465T1 (de)
AU (1) AU648529B2 (de)
CA (1) CA2069002A1 (de)
DE (1) DE69026511T2 (de)
DK (1) DK627289D0 (de)
ES (1) ES2087279T3 (de)
NO (1) NO922136L (de)
WO (1) WO1991008751A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203162T1 (de) * 1992-12-18 2001-08-15 Merck & Co Inc Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
FR2707646A1 (fr) * 1993-07-15 1995-01-20 Univ Toulouse Procédé d'extraction et de purification de saponines hémolytiques.
CA2209315C (en) * 1995-01-06 2009-12-15 Australian Biomedical Company Pty.Ltd. Gibberellins compounds for veterinary and medicinal applications
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
AU2003299660A1 (en) * 2002-12-16 2004-07-22 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
JP5615484B2 (ja) * 2008-01-15 2014-10-29 株式会社 エス・ネット ５α‐リダクターゼ阻害剤
CN102526254B (zh) * 2012-02-08 2013-12-18 李宁 一种治疗男性前列腺炎的中药组合物
JP6761705B2 (ja) * 2016-02-01 2020-09-30 株式会社日本健康食品研究所 ５α−リダクターゼ阻害剤及び泌尿器系疾患治療・予防用組成物ならびにこれらの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex

Also Published As

Publication number Publication date
DK627289D0 (da) 1989-12-12
KR920703088A (ko) 1992-12-17
DE69026511T2 (de) 1996-11-21
AU648529B2 (en) 1994-04-28
AU6913891A (en) 1991-07-18
EP0504254B1 (de) 1996-04-10
NO922136D0 (no) 1992-05-29
JPH05502227A (ja) 1993-04-22
DE69026511D1 (de) 1996-05-15
EP0504254A1 (de) 1992-09-23
NO922136L (no) 1992-05-29
WO1991008751A1 (en) 1991-06-27
CA2069002A1 (en) 1991-06-13
ES2087279T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
DE3752045D1 (de) Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE59309043D1 (de) Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und diese enthaltenden pharmazeutischen Präparaten
ATE330593T1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
HU902854D0 (en) Process for the production of taxol derivatives and medical preparations containing such active agents
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ID945B (id) Turunan-turunan baru kroman dan tiokroman
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE3770465D1 (de) Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE58903917D1 (de) Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels sowie daraus hergestelltes arzneimittel und verfahren zu seiner herstellung.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
IT1240683B (it) Composizione farmaceutica contenente egf
ATE192929T1 (de) Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties